Andér Martin, Luzhkov Victor B, Aqvist Johan
Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.
Biophys J. 2008 Feb 1;94(3):820-31. doi: 10.1529/biophysj.107.112045. Epub 2007 Sep 28.
The binding of blockers to the human voltage-gated Kv1.5 potassium ion channel is investigated using a three-step procedure consisting of homology modeling, automated docking, and binding free energy calculations from molecular dynamics simulations, in combination with the linear interaction energy method. A reliable homology model of Kv1.5 is constructed using the recently published crystal structure of the Kv1.2 channel as a template. This model is expected to be significantly more accurate than earlier ones based on less similar templates. Using the three-dimensional homology model, a series of blockers with known affinities are docked into the cavity of the ion channel and their free energies of binding are calculated. The predicted binding free energies are in very good agreement with experimental data and the binding is predicted to be mainly achieved through nonpolar interactions, whereas the relatively small differences in the polar contribution determine the specificity. Apart from confirming the importance of residues V505, I508, V512, and V516 for ligand binding in the cavity, the results also show that A509 and P513 contribute significantly to the nonpolar binding interactions. Furthermore, we find that pharmacophore models based only on optimized free ligand conformations may not necessarily capture the geometric features of ligands bound to the channel cavity. The calculations herein give a detailed structural and energetic picture of blocker binding to Kv1.5 and this model should thus be useful for further ligand design efforts.
采用三步程序研究阻滞剂与人电压门控Kv1.5钾离子通道的结合,该程序包括同源建模、自动对接以及基于分子动力学模拟结合线性相互作用能方法的结合自由能计算。以最近发表的Kv1.2通道晶体结构为模板构建了可靠的Kv1.5同源模型。预计该模型比基于相似度较低模板的早期模型要准确得多。利用三维同源模型,将一系列具有已知亲和力的阻滞剂对接至离子通道腔中,并计算它们的结合自由能。预测的结合自由能与实验数据非常吻合,且预计结合主要通过非极性相互作用实现,而极性贡献的相对较小差异决定了特异性。除了证实残基V505、I508、V512和V516对腔内配体结合的重要性外,结果还表明A509和P513对非极性结合相互作用有显著贡献。此外,我们发现仅基于优化的游离配体构象的药效团模型不一定能捕捉到与通道腔结合的配体的几何特征。本文的计算给出了阻滞剂与Kv1.5结合的详细结构和能量图景,因此该模型应有助于进一步的配体设计工作。